NCT05913843

Brief Summary

There are more than 7000 known genetic disorders, and the number of affected is estimated to be about 6-10% of the population. Around 30 to 40% of genetic disorders have physical changes in the face and skull such as Down's syndrome or Fragile X syndrome. Therefore, the known facial phenotype of many genetic disorders is highly informative to clinical diagnosis. Since a large number of genetic diseases are associated with special facial phenotypes that are difficult to remember, automated facial analysis such as Face2Gene and GestaltMatcher can assist in the identification and diagnosis of facial phenotypes related to various genetic diseases. Although the current advances in whole exome sequencing (whole exome sequencing) or whole genome sequencing (whole genome sequencing) have greatly improved the diagnostic rate of genetic diseases, about half of the patients are still undiagnosed. For patients with special facial phenotypes, the investigators believe that by combining automated facial analysis and whole exome sequencing data, it should be possible to provide a fast and accurate diagnostic model of genetic mutations for genetic diseases. GestaltMatcher Database is a medical imaging database of rare diseases developed by Professor Peter Krawitz of the University of Bonn, Germany. The database's artificial intelligence module will infer a patient's possible diagnosis based on the patient's photo, age, gender, race, and clinical description. The database will be open to medical researchers in related fields to improve the diagnosis of rare diseases. The investigators will use GestaltMatcher to assist in the diagnosis of patients, and compare the accuracy and significant differences in facial deformities between Taiwanese patients and patients from different countries. And use Eye Tracker to analyze how doctors diagnose patients through facial photos, and compare whether there are significant differences between foreign patients and Taiwanese patients in the diagnosis literature of Taiwanese doctors. The project will also analyze how genetic doctors at the University of Bonn in Germany diagnose patients, and compare it with Taiwanese doctors to better understand the differences in the process of doctors diagnosing patients and ethnic backgrounds.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
1mo left

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress92%
Jul 2024Jun 2026

First Submitted

Initial submission to the registry

May 23, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 22, 2023

Completed
1.1 years until next milestone

Study Start

First participant enrolled

July 30, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

August 20, 2025

Status Verified

August 1, 2025

Enrollment Period

1.9 years

First QC Date

May 23, 2023

Last Update Submit

August 14, 2025

Conditions

Keywords

Automated facial analysis

Outcome Measures

Primary Outcomes (2)

  • The diagnosis accuracy rate of use GestaltMatcher to analysis participant facial features in rare diseases

    GestaltMatcher is a automated facial analysis software, which utilized deep convolutional neural networks trained on patients' photos as an encoder to convert facial photos into feature vectors to form a Clinical Face Phenotype Space (CFPS). And quantified the similarity among patients by the cosine distance of two vectors in CFPS. With this approach, the investigators can support the ultra-rare syndromes that lack images to be trained and push the supported syndromes. Base on on this technology, the investigators use GestaltMatcher to analysis participant facial features and compare those vectors which are similar to patients to find possible syndromes. The investigators will verify more clinical phenotype and genetic data of the participants for verification.

    1 month

  • The significant difference in facial deformities between Taiwan participant and participant from different countries by GestaltMatcher

    The investigators will ues those facial feature vectors from GestaltMatcher Database to compare with Taiwan participants in the research platform within the GestaltMatcher Database to find the facial differences between Taiwan and other different countries participants by pairwise matrix. To find out where is the difference between Taiwan and different countries participants, improving the diagnostic perspectives in Taiwanese groups.

    3 years

Secondary Outcomes (2)

  • Criteria for doctors to diagnose participants from facial features assessed by eye trackers

    3 years

  • Diagnosis differences between Taiwan and Bonn University genetics doctors

    3 years

Interventions

We will use the camera to take 2 front and side images of the participant, and select one of the better images to upload to the facial analysis system (GestaltMatcher Database) for analysis.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Cases with abnormal appearance of clinical symptoms and suspected genetic diseases at National Taiwan University Hospital

You may qualify if:

  • Cases with abnormal appearance of clinical symptoms and suspected genetic diseases

You may not qualify if:

  • Unable to cooperate with the examiner

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 10041, Taiwan

RECRUITING

MeSH Terms

Conditions

Rare Diseases

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Ni-Chung Lee, M.D., Ph.D.

    National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ni-Chung Lee, M.D., Ph.D.

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2023

First Posted

June 22, 2023

Study Start

July 30, 2024

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

August 20, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations